Moldova is preparing changes that could ease regulations on the handling of medications and reduce losses for the market. The changes involve a mechanism that would allow for the retention of usable medications—rather than writing them off or destroying them—after their registration documents expire, provided they remain within their expiration date.
A major new pharmaceutical manufacturing project is being launched in Moldova, which calls for the creation of a modern industrial and innovation cluster. The initiative was presented at an industry forum, where participants also discussed investment opportunities in healthcare, exports, and the development of medical tourism.
As part of Moldova Business Week, a forum dedicated to investment and export potential in the healthcare sector will be held in Moldova. Participants from government agencies, the medical and pharmaceutical sectors, as well as investors and international experts, will discuss the industry's prospects, including the development of clinics, drug manufacturing, and new financing avenues.
Moldova is discussing a major overhaul of pharmaceutical market regulations that could change how medications are accessed in rural areas and expand the range of services offered by pharmacies. The draft law provides for new service models, additional regulatory requirements, and specific support measures for market participants; however, the final details may still be adjusted based on the results of consultations.
Moldova intends to attract new Greek investment into its economy, including in the IT, pharmaceutical, agritourism, and medical tourism sectors
Moldova will be represented by a national booth at CPHI Milan 2026—one of the most important international platforms dedicated to the pharmaceutical industry
Revenues for the mandatory health insurance funds rose significantly over the first seven months of 2026, with insurance premiums and revenues from other sources accounting for the bulk of the increase. At the same time, the system's expenditures exceeded its revenues, and a significant portion of the funds was allocated to pay for medical and pharmaceutical services—the full version of this article presents the key revenue items and expenditure trends.
Moldova will implement a European system for the recognition of medical and pharmaceutical qualifications
Loading…
